Research Paper Volume 14, Issue 9 pp 4107—4136
RecQ mediated genome instability 2 (RMI2): a potential prognostic and immunological biomarker for pan-cancers
Figure 2. Correlation between RMI2 expression in patients with DFI (A). (A) Survival analyses of RMI2 expression via the Kaplan–Meier PFI curves in ACC, CESC, KIRC, LGG, LIHC, LUAD, MESO, PAAD, PCPG, PRAD, SARC and UCEC. Cox proportional risk model was used to study the effect of RMI2 on the prognosis of multiple human tumors (B–E). (B) Effect of RMI2 on OS in 33 human tumors. (C) Effect of RMI2 on DSS in 33 human tumors. (D) Effect of RMI2 on DFS in 33 human tumors. (E) Effect of RMI2 on PFI in 33 human tumors.